Optimization of Darunavir Therapy Through Population Pharmacokinetic Modeling, Simulations and Dosage Guidelines
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Nov 2018
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Darunavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 12 Nov 2018 Planned End Date changed from 1 Sep 2018 to 1 Mar 2019.
- 12 Nov 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Mar 2019.
- 12 Nov 2018 Status changed from recruiting to active, no longer recruiting.